影响COPD及呼吸衰竭预后的相关因素分析
Analysis of Related Factors Affecting Prognosis of COPD and Respiratory Failure
DOI: 10.12677/ACM.2023.13122779, PDF,   
作者: 余 娟, 李英莲*:青海大学附属医院,全科医学科,青海 西宁
关键词: COPD呼吸衰竭炎症营养预后综述COPD Respiratory Failure Inflammation Nutrition Prognosis Summary
摘要: 慢性阻塞性肺疾病及呼吸衰竭的患者,其发病率及死亡率还处于较高水平,已成为我国医疗领域的经济负担。近年来,研究发现,炎症反应水平及营养状况与COPD及呼吸衰竭的发生、发展和患者的预后具有一定的相关性。营养风险筛查NRS2002评分及血清白蛋白水平(ALB)等常用于临床营养评估。营养评估结果不佳的患者,其生活质量和病情演变均呈负向趋势,导致发病率、住院时间、死亡率和卫生支出均增加。早期识别并给予足够的营养支持,才能预防或逆转营养不良。本综述中,通过观察外周血炎症及营养指标,间接反应COPD及呼吸衰竭预后及进展情况,将展开描述主要炎症细胞及营养指标与COPD及呼吸衰竭预后的关系,以及主要炎症细胞在COPD及呼吸衰竭气道重塑中的作用,以期为临床干预提供参考价值。
Abstract: The morbidity and mortality of patients with chronic obstructive pulmonary disease and respirato-ry failure are still at a high level, which has become an economic burden in China’s medical field. In recent years, studies have found that the level of inflammatory response and nutritional status are related to the occurrence, development and prognosis of patients with COPD and respiratory failure. Nutritional risk screening NRS2002 score and serum albumin level (ALB) are commonly used in clinical nutritional assessment. Patients with poor nutritional assessments have negative trends in both quality of life and disease evolution, resulting in increased morbidity, length of hospital stay, mortality, and health expenditures. Early recognition and adequate nutritional support can prevent or reverse malnutrition. In this review, the relationship between major inflammatory cells and nu-tritional markers and the prognosis of COPD and respiratory failure will be described by observing the peripheral blood inflammation and nutritional indicators, which indirectly reflect the prognosis and progression of COPD and respiratory failure, and the role of major inflammatory cells in COPD and respiratory failure airway remodeling, in order to provide reference value for clinical interven-tion.
文章引用:余娟, 李英莲. 影响COPD及呼吸衰竭预后的相关因素分析[J]. 临床医学进展, 2023, 13(12): 19745-19752. https://doi.org/10.12677/ACM.2023.13122779

参考文献

[1] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组, 中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病诊治指南(2021年修订版) [J]. 中华结核和呼吸杂志, 2021, 44(3): 170-205.
[2] Villgran, V.D., Lyons, C., Nasrullah, A., Clarisse Abalos, C., Bihler, E. and Alhajhusain, A. (2022) Acute Respiratory Failure. Critical Care Nursing Quarterly, 45, 233-247. [Google Scholar] [CrossRef
[3] Mizobuchi, K., Jujo, K., Minami, Y., Ishida, I., Nakao, M. and Hagiwara, N. (2019) The Baseline Nutritional Status Predicts Long-Term Mortality in Patients Undergoing Endovascular Therapy. Nutrients, 11, Article No. 1745. [Google Scholar] [CrossRef] [PubMed]
[4] Wang, Y., Xu, J., Meng, Y., Adcock, I.M. and Yao, X. (2018) Role of Inflammatory Cells in Airway Remodeling in COPD. The International Journal of Chronic Obstructive Pulmonary Disease, 13, 3341-3348. [Google Scholar] [CrossRef
[5] Richmond, B.W., Du, R.H., Han, W., Benjamin, J.T., van der Meer, R., Gleaves, L., et al. (2018) Bacterial-Derived Neutrophilic Inflammation Drives Lung Remodeling in a Mouse Model of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory Cell and Molecular Biology, 58, 736-744. [Google Scholar] [CrossRef
[6] Hirota, N. and Martin, J.G. (2013) Mechanisms of Airway Re-modeling. Chest, 144, 1026-1032. [Google Scholar] [CrossRef] [PubMed]
[7] Hogg, J.C. and Timens, W. (2009) The Pathology of Chronic Obstruc-tive Pulmonary Disease. Annual Review of Pathology, 4, 435-459. [Google Scholar] [CrossRef] [PubMed]
[8] Sohal, S.S., Ward, C., Danial, W., Wood-Baker, R. and Walters, E.H. (2013) Recent Advances in Understanding Inflammation and Remodeling in the Airways in Chronic Obstructive Pulmonary Disease. Expert Review of Respiratory Medicine, 7, 275-288. [Google Scholar] [CrossRef] [PubMed]
[9] Mendy, A., Forno, E., Niyonsenga, T. and Gasana, J. (2018) Blood Bi-omarkers as Predictors of Long-Term Mortality in COPD. The Clinical Respiratory Journal, 12, 1891-1899. [Google Scholar] [CrossRef] [PubMed]
[10] Bartoli, M.L., Costa, F., Malagrinò, L., et al. (2016) Sputum Inflammatory Cells in COPD Patients Classified According to GOLD 2011 Guidelines. European Respiratory Journal, 47, 978-980. [Google Scholar] [CrossRef] [PubMed]
[11] Wang, Y., Jia, M., Yan, X., et al. (2017) Increased Neutrophil Gelatinase-Associated Lipocalin (NGAL) Promotes Airway Remodelling in Chronic Obstructive Pulmonary Disease. Clinical Science (London), 131, 1147-1159. [Google Scholar] [CrossRef
[12] Ostridge, K., Williams, N., Kim, V., et al. (2016) Relationship between Pulmonary Matrix Metalloproteinases and Quantitative CT Markers of Small Airways Disease and Emphysema in COPD. Thorax, 71, 126-132. [Google Scholar] [CrossRef] [PubMed]
[13] Polverino, E., Rosales-Mayor, E., Dale, G.E., Dembowsky, K. and Torres, A. (2017) The Role of Neutrophil Elastase Inhibitors in Lung Diseases. Chest, 152, 249-262. [Google Scholar] [CrossRef] [PubMed]
[14] Guo, Y., Ma, L., Zhang, F., Sun, R. and Li, T. (2016) Neutrophil Elastase Ameliorates Matrix Metalloproteinase-9 to Promote Lipopolysaccharide-Induced Acute Lung Injury in Mice. Acta Cirúrgica Brasileira, 31, 382-388. [Google Scholar] [CrossRef
[15] Nauseef, W.M. (2018) Biosynthesis of Human Myeloperoxidase. Archives of Biochemistry and Biophysics, 642, 1-9. [Google Scholar] [CrossRef] [PubMed]
[16] Churg, A., Marshall, C.V., Sin, D.D., et al. (2012) Late Intervention with a Myeloperoxidase Inhibitor Stops Progression of Experimental Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 185, 34-43. [Google Scholar] [CrossRef
[17] Brusselle, G.G., Joos, G.F. and Bracke, K.R. (2011) New In-sights into the Immunology of Chronic Obstructive Pulmonary Disease. The Lancet, 378, 1015-1026. [Google Scholar] [CrossRef
[18] Aurora, A.B., Baluk, P., Zhang, D., et al. (2005) Immune Complex-Dependent Remodeling of the Airway Vasculature in Response to a Chronic Bacterial Infection. The Journal of Immunology, 175, 6319-6326. [Google Scholar] [CrossRef] [PubMed]
[19] Kim, W.D., Chi, H.S., Choe, K.H., et al. (2013) A Possible Role for CD8+ and Non-CD8+ Cell Granzyme B in Early Small Airway Wall Remodelling in Centrilobular Emphysema. Respirology, 18, 688-696. [Google Scholar] [CrossRef] [PubMed]
[20] Majo, J., Ghezzo, H. and Cosio, M.G. (2001) Lymphocyte Population and Apoptosis in the Lungs of Smokers and Their Relation to Emphysema. European Respiratory Journal, 17, 946-953. [Google Scholar] [CrossRef] [PubMed]
[21] Bracke, K.R., Verhamme, F.M., Seys, L.J., et al. (2013) Role of CXCL13 in Cigarette Smoke-Induced Lymphoid Follicle Formation and Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 188, 343-355. [Google Scholar] [CrossRef
[22] Tan, H.L. and Rosenthal, M. (2013) IL-17 in Lung Disease: Friend or Foe? Thorax, 68, 788-790. [Google Scholar] [CrossRef] [PubMed]
[23] Arora, S., Dev, K., Agarwal, B., Das, P. and Syed, M.A. (2018) Macrophages: Their Role, Activation and Polarization in Pulmonary Diseases. Immunobiology, 223, 383-396. [Google Scholar] [CrossRef] [PubMed]
[24] Barnes, P.J. (2014) Cellular and Molecular Mechanisms of Chronic Obstructive Pulmonary Disease. Clinics in Chest Medicine, 35, 71-86. [Google Scholar] [CrossRef] [PubMed]
[25] Jundi, K. and Greene, C.M. (2015) Transcription of Interleukin-8: How Altered Regulation Can Affect Cystic Fibrosis Lung Disease. Biomolecules, 5, 1386-1398. [Google Scholar] [CrossRef] [PubMed]
[26] Churg, A., Zhou, S., Wang, X., Wang, R. and Wright, J.L. (2009) The Role of Interleukin-1beta in Murine Cigarette Smoke-Induced Emphysema and Small Airway Remodeling. American Journal of Respiratory Cell and Molecular Biology, 40, 482-490. [Google Scholar] [CrossRef
[27] Trojanek, J.B., Cobos-Correa, A., Diemer, S., et al. (2014) Air-way Mucus Obstruction Triggers Macrophage Activation and Matrix Metalloproteinase 12-Dependent Emphysema. American Journal of Respiratory Cell and Molecular Biology, 51, 709-720. [Google Scholar] [CrossRef
[28] Yoshimura, T. (2018) The Chemokine MCP-1 (CCL2) in the Host Interaction with Cancer: A Foe or Ally? Cellular & Molecular Immunology, 15, 335-345. [Google Scholar] [CrossRef] [PubMed]
[29] Qian, M., Fang, X. and Wang, X. (2017) Autophagy and Inflammation. Clinical and Translational Medicine, 6, Article No. 24. [Google Scholar] [CrossRef] [PubMed]
[30] Erjefält, J.S. (2014) Mast Cells in Human Airways: The Culprit? European Respiratory Review, 23, 299-307. [Google Scholar] [CrossRef] [PubMed]
[31] Virk, H., Arthur, G. and Bradding, P. (2016) Mast Cells and Their Activation in Lung Disease. Translational Research, 174, 60-76. [Google Scholar] [CrossRef] [PubMed]
[32] Li, H., Yang, T., Ning, Q., et al. (2015) Cigarette Smoke Ex-tract-Treated Mast Cells Promote Alveolar Macrophage Infiltration and Polarization in Experimental Chronic Obstructive Pulmonary Disease. Inhalation Toxicology, 27, 822-831. [Google Scholar] [CrossRef] [PubMed]
[33] Kosanovic, D., Dahal, B.K., Peters, D.M., et al. (2014) His-tological Characterization of Mast Cell Chymase in Patients with Pulmonary Hypertension and Chronic Obstructive Pul-monary Disease. Pulmonary Circulation, 4, 128-136. [Google Scholar] [CrossRef] [PubMed]
[34] Mortaz, E., Folkerts, G. and Redegeld, F. (2011) Mast Cells and COPD. Pul-monary Pharmacology & Therapeutics, 24, 367-372. [Google Scholar] [CrossRef] [PubMed]
[35] Planas, M. and Burgos, R. (2000) Nutrición e insuficiencia respiratoria [Nutrition and Respiratory Insufficiency]. Nutrición Hospi-talaria, 15, 93-100.
[36] Vincent, J.L. (2009) Relevance of Albumin in Modern Critical Care Medicine. Best Practice & Research Clinical Anaesthesiology, 23, 183-191. [Google Scholar] [CrossRef] [PubMed]
[37] Taverna, M., Ma-rie, A.L., Mira, J.P. and Guidet, B. (2013) Specific Antioxidant Properties of Human Serum Albumin. Annals of Inten-sive Care, 3, Article No. 4. [Google Scholar] [CrossRef] [PubMed]
[38] Wiedermann, C.J. (2021) Hypoalbu-minemia as Surrogate and Culprit of Infections. International Journal of Molecular Sciences, 22, Article No. 4496. [Google Scholar] [CrossRef] [PubMed]
[39] Iglesias, J., Abernethy, V.E., Wang, Z., Lieberthal, W., Koh, J.S. and Levine, J.S. (1999) Albumin Is a Major Serum Survival Factor for Renal Tubular Cells and Macrophages through Scav-enging of ROS. American Journal of Physiology, 277, F711-F722. [Google Scholar] [CrossRef
[40] Phillips, A., Shaper, A.G. and Whincup, P.H. (1989) Asso-ciation between Serum Albumin and Mortality from Cardiovascular Disease, Cancer, and Other Causes. The Lancet, 2, 1434-1436. [Google Scholar] [CrossRef
[41] Shen, S. and Xiao, Y. (2023) Association between C-Reactive Protein and Albumin Ratios and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease. The International Journal of Chronic Obstructive Pulmonary Disease, 18, 2289-2303. [Google Scholar] [CrossRef
[42] Baldemir, R., Öztürk, A., Eraslan Doganay, G., Cirik, M.O. and Alagoz, A. (2022) Evaluation of Nutritional Status in Hospitalized Chronic Obstructive Pulmonary Disease Patients and Can C-Reactive Protein-to-Albumin Ratio Be Used in the Nutritional Risk Assessment in These Patients. Cureus, 14, e21833. [Google Scholar] [CrossRef] [PubMed]
[43] Wedzicha, J.A., Syndercombe-Court, D. and Tan, K.C. (1991) Increased Platelet Aggregate Formation in Patients with Chronic Airflow Obstruction and Hypoxaemia. Thorax, 46, 504-507. [Google Scholar] [CrossRef] [PubMed]
[44] Wedzicha, J.A., Cotter, F.E. and Empey, D.W. (1988) Platelet Size in Patients with Chronic Airflow Obstruction with and without Hypoxaemia. Thorax, 43, 61-64. [Google Scholar] [CrossRef] [PubMed]
[45] Liang, L.S., Mo, Y., Zhang, Z.Y., Liang, P.S. and Xu, P. (2022) Progress in Platelets and Chronic Obstructive Pulmonary Disease. Chinese Journal of Tuberculosis and Respiratory Diseases, 45, 1050-1054.
[46] Hodgson, L. (2014) Predicting Death or Deterioration in Patients Admitted with Acute Exacerbation of COPD Using Physiological and Blood Parameters. Thorax, 69, A18. [Google Scholar] [CrossRef
[47] Benedik, B., Farkas, J., Kosnik, M., et al. (2011) Mini Nu-tritional Assessment, Body Composition, and Hospitalisations in Patients with Chronic Obstructive Pulmonary Disease. Respiratory Medicine, 105, S38-S43. [Google Scholar] [CrossRef
[48] Almeida, A.I., Correia, M., Camilo, M. and Ravasco, P. (2012) Nutritional Risk Screening in Surgery: Valid, Feasible, Easy! Clinical Nutrition, 31, 206-211. [Google Scholar] [CrossRef] [PubMed]
[49] Cui, J., Wan, Q., Wu, X., Zeng Y, et al. (2015) Nutritional Risk Screening 2002 as a Predictor of Outcome during General Ward-Based Noninvasive Ventilation in Chronic Obstructive Pulmonary Disease with Respiratory Failure. Medical Science Monitor, 21, 2786-2793. [Google Scholar] [CrossRef